Abstract
We have previously reported the construction of Staphylococcus aureus integration vectors based on the staphylococcal pathogenicity island 1 (SaPI1) site-specific recombination system. These are shuttle vectors that can be propagated in Escherichia coli, which allows for standard DNA manipulations. In S. aureus, these vectors are temperature-sensitive and can only be maintained at non-permissive (42 °C) temperatures by integrating into the chromosome. However, most S. aureus strains are sensitive to prolonged incubations at higher temperatures and will rapidly accumulate mutations, making the use of temperature-sensitive integration vectors impractical for single-copy applications. Here we describe improved versions of these vectors, which are maintained only in single-copy at the SaPI1 attachment site. In addition, we introduce several additional cassettes containing resistance markers, expanding the versatility of integrant selection, especially in strains that are resistant to multiple antibiotics.
Keywords: Single-copy, Integration, SaPI, Complementation
1. Introduction
Staphylococcus aureus is a leading cause of bacterial infections and mortality worldwide (Klein et al., 2007; Naimi et al., 2003). The construction and study of isogenic genetic mutants in this, or any pathogen, is key to the delineation of its virulence and physiological mechanisms. However, secondary mutations can arise during the process of gene inactivation, hence interpretation of data garnered from such strains can potentially lead researchers to aberrant conclusions with regard to the true function of their gene of interest (Labandeira-Rey et al., 2007; Sun et al., 2010; Villaruz et al., 2009; Wyatt et al., 2010). Hence, upon inactivation of any gene, complementation of that same locus is necessary. The complemented mutant should regain a phenotype comparable to that of the wildtype strain, affirming that any phenotypes observed in the genetic knockout were not attributed to secondary mutations.
Complementation with the wildtype gene on an autonomously replicating plasmid is a strategy that is commonly used in S. aureus (Bubeck Wardenburg et al., 2006; Yoong and Pier, 2012). The wildtype locus and its native promoter region (or that of a different promoter fused upstream of the gene) can be cloned into the plasmid vector, and transformed into the knockout strain. While complementation in the knockout strain can be achieved from a plasmid, the amount of wildtype proteins expressed can differ significantly from that of the parental strain, commonly higher than wildtype, due in part to the multi-copy nature of most plasmid vectors. The maintenance of plasmids can also be an issue should selective pressure be removed, say in experiments involving animal infections. A more stable and accurate system of complementation would be the integration of the wildtype gene coupled with its native regulatory sequences. Two such complementation strategies have been used in S. aureus, involving integration into the phi11 or L54 phage attachment sites (Luong and Lee, 2007). While the basis of these complementation systems is sound, there are limitations, depending on the strain of study. Many S. aureus strains are lysogenic with a resident prophage at the phi11 or L54 attachment sites, and integrating a vector at these attachment sites will cure the strain of the respective phage. The deletion of a phage may significantly alter a strain, since many S. aureus phages are important contributors to pathogenesis (Bae et al., 2006; Novick et al., 2001; van Wamel et al., 2006). In strains that do not carry a prophage at the L54 attachment site, integration of a plasmid disrupts the major lipase gene, geh, which has been implicated in virulence (Hu et al., 2012). Hence, genetic complementation in the lipase gene can alter the virulence of the strain, a trait that is undesirable, especially if the pathogenesis of S. aureus is being studied.
Here, we describe an additional system that enables the integration of genes into the S. aureus chromosome. This system is based on integration into the chromosomal attachment site (attC) of the S. aureus pathogenicity island 1 (SaPI1) (Lindsay et al., 1998; Ubeda et al., 2009). There are five known SaPI attC sites, and all five are present in every S. aureus genome sequenced to date. Each insertion site is located at the 3′ end of a gene, such that integration does not disrupt that gene (Novick et al., 2010). We also developed several cassettes containing resistance markers that are selectable in single copy, expanding the versatility of integrant selection, especially in strains that are resistant to multiple antibiotics. In this report, we highlight the stability of the SaPI1 site-specific integrated vectors. Additionally, we present a comparison of gene function restoration using the SaPI1 integrated vectors with that of an extrachromosomal plasmid vector. Taken together, these features of the SaPI1 integration vectors greatly advance the set of genetic tools available for the study of S. aureus physiology and pathogenesis.
2. Materials and methods
2.1. Bacterial strains and growth conditions
The S. aureus strains and plasmids used in this study are listed in Table 1.
Table 1.
Strains, plasmids, and primers used in this study.
|
S. aureus strains
| ||
|---|---|---|
| Strain | Genotype or description | Reference |
| JCSA359 | S. aureus strain RN6734/pJC1280 | This work |
| JCSA362 | S. aureus strain RN6734/pJC1349 | This work |
| JCSA367 | S. aureus strain RN6734 SaPI1 attC∷pJC1358 | This work |
| JCSA370 | S. aureus strain RN6734 SaPI1 attC∷pJC1359 | This work |
| RN9011 | S. aureus strain RN4220/pRN7023 (SaPI1 integrase, cat194) | (Ruzin et al., 2001) |
| JCSA1155 | S. aureus strain RN450 SaPI1 attC∷pJC1111 | This work |
|
| ||
|
Plasmids
| ||
|
Integration vectors
| ||
| Plasmid | Description | Reference |
|
| ||
| pJC1110 | SaPI1 attS suicide vector, chloramphenicol resistant (cat194) | This work |
| pJC1111 | SaPI1 attS suicide vector, cadmium resistant (cadCA) | (Geisinger et al., 2008) |
| pJC1112 | SaPI1 attS suicide vector, erythromycin resistant (ermC) | This work |
| pJC1302 | SaPI1 attS suicide vector, arsenite resistant (arsABC) | This work |
| pJC1306 | SaPI1 attS suicide vector, tetracycline resistant (tetM) | This work |
|
| ||
|
Cloning of antibiotic resistance cassettes
| ||
| Plasmid | Description | Reference |
|
| ||
| pJC1071 | pUC18 PCR JCO 124 + JCO 125 on pI524, amplifies cadCA | This work |
| pJC1300 | pUC18 PCR JCO 212 + JCO 213 on pI258, amplifies arsABC | This work |
| pJC1305 | pUC18 PCR JCO 389 + JCO 398 on SaPI1 tsst1∷tetM, amplifies tetM | This work |
|
| ||
|
Reporter fusions
| ||
| Plasmid | Description | Reference |
|
| ||
| pJC1280 | blaZ transcriptional reporter, pT181 replicon (cat194) | (Geisinger et al., 2012) |
| pJC1349 | P3-blaZ transcriptional fusion. P3 promoter cloned into pJC1280 (cat194) | (Geisinger et al., 2012) |
| pJC1358 | blaZ transcriptional reporter, cloned into pJC1111 (cadCA) | This work |
| pJC1359 | P3-blaZ transcriptional fusion. P3 promoter cloned into pJC1358 (cadCA) | This work |
|
| ||
|
PVL complementation constructs
| ||
| Plasmid | Description | Reference |
|
| ||
| pJC1111-ppvl | pvl genes with its native promoter cloned into pJC1111 | This work |
| pOS1-ppvl | pvl genes with its native promoter cloned into pOS1 | (Yoong and Pier, 2012) |
|
| ||
|
Primers
| ||
| Sequence (5′-3′) | Reference | |
|
| ||
| JCO 124 | 5′-CCTAGGGTCATACCCTGGTCAAAACCGTTCG-3′ | This work |
| JCO 125 | 5′-CCGCGGCCGCAGCTGCTGTAAGTATCG-3′ | This work |
| JCO 212 | 5′-CCTAGCTCAAGGGATTCAAGTCGCC-3′ | This work |
| JCO 213 | 5′-CCGCGGAGCGTTTCTCACAGCG-3′ | This work |
| JCO 389 | 5′-CCTAGGATCAAGAAACAAAGGCAACCC-3′ | This work |
| JCO 398 | 5′-CCGCGGATCTTGTATCATTACTCCATGTATC-3′ | This work |
| JCO 717 | 5′-GTGCTTCACCAGCACCACATGCTG-3′ | This work |
| JCO 719 | 5′-GGTATTAGTTTGAGCTGTCTTGGTTCATTGATTGC-3′ | This work |
Cloning was performed with Escherichia coli strains DH5α and Top Ten. All clones were transformed into S. aureus strain RN4220, our standard recipient for E. coli DNA, or its derivative containing the site-specific SaPI1 integrase (RN9011) before phage transduction to other S. aureus strains. S. aureus cells from overnight plates containing the appropriate selective antibiotics (tetracycline 10 μg/mL, chloramphenicol 10 μg/mL, erythromycin 5 μg/mL cadmium chloride [CdCl2] 0.1 mM and/or sodium arsenite [NaAsO2] 0.5–1.0 mM) were used as base inocula for all experiments. Clones selected on sodium arsenite were transferred to non-selective media for maintenance and storage within 1 day.
2.2. Plasmid construction
The plasmids used in this study were constructed by cloning PCR products amplified with oligonucleotide primers purchased from Integrated DNA Technologies (Coralville, IA) (see Table 1). Clones were sequenced by Macrogen (Rockville, MD). Blunt PCR products were cloned into the HincII site of pUC18. A SaPI1 integration vector with a temperature sensitive pT181 replicon (Novick et al., 1982), pJC1079, was digested with HpaI and self-ligated to delete the pT181 replicon to generate pJC1110. The cadmium chloride resistance cadCA cassette from pJC1071 (AvrII-SacII), with the same restriction sites as the resistance cassettes described by Charpentier et al. (2004), replaced the chloramphenicol resistance cat194 gene on pJC1110 to generate pJC1111. The erythromycin resistance ermC cassette from pCN33 (AvrII-SacII) (Charpentier et al., 2004) replaced cat194 on pJC1110 to generate pJC1112. The sodium arsenite resistance arsABC cassette from pJC1300 (AvrII-SacII) replaced cat194 on pJC1100 to generate pJC1302. The tetracycline resistance tetM cassette from pJC1305 (AvrII-SacII) replaced cat194 on pJC1110 to generate pJC1306. While the base vector originated with multiple cloning sites from pUC19, some sites are no longer unique, depending on the vector. The available cloning sites in all SaPI1 integration vectors are summarized in Fig. 1.
Fig. 1.

Map of multi-cloning sites of the SaPI1 integration vectors.
Plasmid pJC1111, which contains a cadmium resistance cassette and the SaPI1 attS sequence was used as the backbone vector for β-lactamase (blaZ) fusion constructs using the polylinker of pUC18. pJC1111 derivatives were integrated into the S. aureus genome at the SaPI1 attC site by electroporation into RN9011. An agrp3 β-lactamase reporter was constructed by moving the agrp3-blaZ fragment from pJC1349 (containing promoter agrp3 cloned from RN6734) (Geisinger et al., 2012).
2.3. Reporter assays
Bacteria containing β-lactamase fusions were transferred from overnight plates and washed once, then inoculated into casamino acids–yeast extract–glycerophosphate (CYGP) without glucose at OD600 of 0.005. Cells were grown at 37 °C with shaking to OD600 of 0.05 and were diluted with fresh media to OD600 of 0.01, representing T0 and corresponding to approximately 107 CFU/mL. This dilution step permitted further reduction of residual agr and reporter transcripts, cell density normalization, and synchronization in early exponential phase. Subsequent growth in CYGP broth without glucose or antibiotics was performed at 37 °C with shaking. Cell density was determined by using a ThermoMax microplate reader (Molecular Devices) to measure the optical density at 600 nm (OD600) of 100 μL samples in 96-well round-bottom assay plates. Samples were collected at the indicated time points and stored at −80 °C. Samples were thawed on ice and diluted with media to appropriate densities for turbidity measurements and assays. Assay of β-lactamase activity was performed by the nitrocefin method as described previously (Ji et al., 1995). Assay data were normalized to β-lactamase units (Vmax/OD600).
2.4. Plasmid stability assay
Strain JCSA1155 was grown overnight on tryptic soy agar (TSA) plates with selection (0.1 mM CdCl2) at 37 °C. Cells were resuspended in tryptic soy broth (TSB) without antibiotics and adjusted to OD600 = 0.5 and diluted 10-6 in TSB without antibiotics and shaken at 37 °C. Every 12 hours, cultures were readjusted to OD600 = 0.5, diluted 10-6 in TSB, and this cycle was repeated to maintain exponential growth until the strains had grown approximately 70–80 generations. Serial dilutions of the cultures were plated on TSA without selection for single colonies, and plasmid retention was measured by picking 100 colonies from the non-selective plates onto plates with selection (0.1 mM CdCl2).
3. Results and discussion
3.1. Plasmid backbone
A modular shuttle vector built previously in this laboratory (Charpentier et al., 2004) was used as the basis of this system of gene complementation. The ColE1 replicon for plasmid replication in E. coli, and the multiple cloning site (MCS), both derived from pUC19, were retained from the pCN vectors. However, the replicon for S. aureus was deleted here, making this a suicide vector in S. aureus.
3.2. Selection markers
We employ four different markers for the selection of this integration vector. The erythromycin resistance cassette was retained from the pCN plasmids (Charpentier et al., 2004). In addition, we are introducing cassettes containing genes coding for resistance to tetracycline, cadmium chloride and sodium arsenite. Distinct pairs of restriction sites flank the genes encoding for proteins that confer resistance, thus making the selection marker modules interchangeable.
3.3. Site-specific integration into the S. aureus chromosome
The attachment sites of SaPI1 (attS) on the plasmids are necessary for recombination of the plasmid into the complementary SaPI1 attachments site within the S. aureus genome (attC). Also required is the integrase specific to SaPI1 that catalyses the crossover. The SaPI1 integrase was cloned into a second plasmid (pRN7023) that is selectable by chloramphenicol.
3.4. Strategy
The gene to be complemented, and its promoter elements, can be cloned into the MCS and propagated in E. coli. Purified plasmids are then transformed into the restriction deficient S. aureus strain carrying the appropriate integrase plasmid (RN9011). Integrative recombination of the plasmid is carried out on media containing the appropriate selective chemical(s), depending on the marker that is being used. Plasmids that fail to undergo recombination will be lost due to lack of a S. aureus replicon. Once integrated, the plasmid can be moved by phage-mediated generalized transduction to any strain of choice. However, similarly to the phi11 or L54 phage attachment sites systems, the SaPI1 integration vectors will cure a strain of a resident SaPI element at the SaPI1 attC site when introduced by transduction.
3.5. Integration and excision at the SaPI1 attC site
3.5.1. Frequency of integration into the SaPI1 attC site
Previously, we reported that SaPIs readily integrate into alternative sites in the absence of the cognate attC site (Chen and Novick, 2009). To determine the frequency of integration at the SaPI1 attC site, we performed PCR analysis on 50 independent transformants of strain RN9011 with pJC1111, using one primer (JCO717) specific to the chromosome and another primer (JCO719) specific to a common region in the integration vectors to amplify an integration junction (Fig. 2A). All 50 transformants gave an amplimer of the expected size of 1.1 kb (20 representative transformants are shown in Fig. 2B), showing that all of the transformants had pJC1111 integrated at the SaPI1 attC site in the correct orientation, indicating that the integration vectors will insert into the SaPI1 attC site most of the time when it is present.
Fig. 2.

(A) S. aureus NCTC 8325 chromosomal region containing the SaPI1 attC site. A generic integrant is shown, which results in the duplication of the SaPI1 attC site. Large arrows represent ORFs and small arrows indicate the annealing positions and directions of primers JCO717 and JCO719. (B) PCR analysis of 20 independent transformants of strain RN9011 with pJC1111. Lane 1 = 1 kb ladder (NEB) in both gels. 1–20 = 20 independent transformants. The expected size of the amplimer with primers JCO 717 and JCO 719 is approximately 1.1 kb.
3.5.2. Frequency of spontaneous excision from the SaPI1 attC site
SaPI elements have been observed to excise spontaneously at low frequencies (Novick et al., 2010); however, because the integration vectors do not carry genes for excision, they are not predicted to excise spontaneously. To determine the stability of the SaPI1 integration vectors, pJC1111 was moved to a phage and SaPI-free strain (RN450) by transduction and the spontaneous excision rates of pJC1111 in three independent transductants (JCSA1155) were measured by testing for loss of cadmium resistance during growth without antibiotic selection. Since the integration vectors are unable to replicate episomally in S. aureus, they can only be maintained as integrants in the chromosome. As shown in Fig. 3, cadmium resistance was not detectably lost in the course of many generations, indicating that the integrated vectors are highly stable without selection and rarely excise spontaneously.
Fig. 3.

Vectors integrated at the SaPI1 attC site are stably maintained without antibiotic selection. Plasmid loss in strain JCSA1155 was assayed by growing cells in the absence of selection for several generations. Cells were plated at regular intervals on TSA without selection for single colonies, and plasmid retention was measured by picking colonies from the non-selective plates onto plates with selection. Values are means ± SD (n = 3 independent samples).
3.6. Comparing gene expression from integrated and extrachromosomal plasmids
3.6.1. Single and multi-copy agrp3-blaZ reporter fusions
β-Lactamase transcriptional reporters were fused to a promoter of the S. aureus agr regulon (agrp3). This fusion construct was cloned into the SaPI1 integration vector pJC1111 (giving rise to pJC1359) followed by subsequent integration into the S. aureus chromosome, in addition to the autonomously replicating vector pJC1280 (giving rise to pJC1349). Ten independent clones of each were selected at random for measurement of β-lactamase activity. Figure 4 shows comparable β-lactamase activity from 10 independent integrated agrp3-blaZ constructs of pJC1359. β-Lactamase activity from the SaPI1 attC integrated reporter vector was highly consistent from all clones, at or near 3000 units. In contrast, 10 clones of S. aureus carrying the agrp3-blaZ reporter on the independently replicating plasmid pJC1349 yielded highly variable β-lactamase readings ranging from ~400 to 1100 units (Fig. 5).
Fig. 4.

Beta-lactamase activity from single copy blaZ fusion vectors chromosomally integrated at the SaPI1 attachment site. V = promoterless blaZ transcriptional reporter (pJC1358). 1–10 = 10 independent clones of agrp3 promoter-blaZ fusion vector (pJC1359).
Fig. 5.

Beta-lactamase activity from blaZ fusion vectors that replicate independently of the chromosome (episomal plasmids). V = promoterless blaZ transcriptional reporter (pJC1280). 1–10 = 10 independent clones of agrp3 promoter-blaZ fusion vector (pJC1349).
3.6.2. Complementation of PVL in a Δpvl strain
The genes encoding for PVL, with their native regulatory elements, were cloned into pJC1111 and into the multicopy plasmid pOS1, giving rise to pJC1111-ppvl and pOS1-ppvl (Yoong and Pier, 2012), respectively. The pJC1111-ppvl construct was integrated into the SaPI1 attC site in the chromosome, while pOS1-ppvl replicated autonomously. Western blots were conducted to detect relative levels of PVL in culture supernatants from the different strains. The blots showed pJC1111-ppvl restoring PVL levels similar to the WT strain (Fig. 6). The multicopy plasmid pOS1-ppvl produced PVL at levels that were significantly higher than the WT strain.
Fig. 6.

Western blots showing relative PVL levels in culture supernatants of S. aureus strains. Isogenic WT and ΔPVL knockout of strain MW2 were used as standards. A faint cross-reactivity with leukocidin ED is normally observed with ΔPVL knockout strains. PVL was complemented in a ΔPVL strain by single crossover of pJC1111-ppvl into the SaPI1 site, and on a multicopy plasmid (pOS1-ppvl). The pJC1111-ppvl construct restored PVL levels comparable to that of the WT strain. The multicopy plasmid, however, produced an overabundance of PVL many fold higher than the WT strain.
4. Conclusions
Taken together, these experiments show that gene expression from autonomously replicating plasmids can vary greatly, as seen with the agrp3 transcriptional fusions, and differ significantly from chromosomal gene expression. Single copy maintenance on the S. aureus chromosome eliminated genetic instability and expression variability. In addition, genetic complementation from the SaPI1 attC site can greatly advance the study of S. aureus pathogenesis by restoring gene expression in mutant strains that approximate physiological wildtype levels. The advantages offered by the SaPI1 integration make these the next generation of S. aureus genetic tools.
Acknowledgments
This work was supported by grant R01AI022159 to RPN and JRP, from the National Institutes of Health (NIH).
References
- Bae T, et al. Prophages of Staphylococcus aureus Newman and their contribution to virulence. Mol Microbiol. 2006;62:1035–1047. doi: 10.1111/j.1365-2958.2006.05441.x. [DOI] [PubMed] [Google Scholar]
- Bubeck Wardenburg J, et al. Host defenses against Staphylococcus aureus infection require recognition of bacterial lipoproteins. Proc Natl Acad Sci U S A. 2006;103:13831–13836. doi: 10.1073/pnas.0603072103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Charpentier E, et al. Novel cassette-based shuttle vector system for gram-positive bacteria. Appl Environ Microbiol. 2004;70:6076–6085. doi: 10.1128/AEM.70.10.6076-6085.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chen J, Novick RP. Phage-mediated intergeneric transfer of toxin genes. Science. 2009;323:139–141. doi: 10.1126/science.1164783. [DOI] [PubMed] [Google Scholar]
- Geisinger E, et al. Identification of ligand specificity determinants in AgrC, the Staphylococcus aureus quorum-sensing receptor. J Biol Chem. 2008;283:8930–8938. doi: 10.1074/jbc.M710227200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Geisinger E, et al. Allele-dependent differences in quorum-sensing dynamics result in variant expression of virulence genes in Staphylococcus aureus. J Bacteriol. 2012;194:2854–2864. doi: 10.1128/JB.06685-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hu C, et al. Functional characterization of lipase in the pathogenesis of Staphylococcus aureus. Biochem Biophys Res Commun. 2012;419:617–620. doi: 10.1016/j.bbrc.2012.02.057. [DOI] [PubMed] [Google Scholar]
- Ji G, et al. Cell density control of staphylococcal virulence mediated by an octapeptide pheromone. Proc Natl Acad Sci U S A. 1995;92:12055–12059. doi: 10.1073/pnas.92.26.12055. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Klein E, et al. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999–2005. Emerg Infect Dis. 2007;13:1840–1846. doi: 10.3201/eid1312.070629. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Labandeira-Rey M, et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science. 2007;315:1130–1133. doi: 10.1126/science.1137165. [DOI] [PubMed] [Google Scholar]
- Lindsay JA, et al. The gene for toxic shock toxin is carried by a family of mobile pathogenicity islands in Staphylococcus aureus. Mol Microbiol. 1998;29:527–543. doi: 10.1046/j.1365-2958.1998.00947.x. [DOI] [PubMed] [Google Scholar]
- Luong TT, Lee CY. Improved single-copy integration vectors for Staphylococcus aureus. J Microbiol Methods. 2007;70:186–190. doi: 10.1016/j.mimet.2007.04.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Naimi TS, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA. 2003;290:2976–2984. doi: 10.1001/jama.290.22.2976. [DOI] [PubMed] [Google Scholar]
- Novick RP, et al. Coding sequence for the pT181 repC product: a plasmid-coded protein uniquely required for replication. Proc Natl Acad Sci U S A. 1982;79:4108–4112. doi: 10.1073/pnas.79.13.4108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Novick RP, et al. Pathogenicity and resistance islands of staphylococci. Microbes Infect. 2001;3:585–594. doi: 10.1016/s1286-4579(01)01414-9. [DOI] [PubMed] [Google Scholar]
- Novick RP, et al. The phage-related chromosomal islands of Gram-positive bacteria. Nat Rev Microbiol. 2010;8:541–551. doi: 10.1038/nrmicro2393. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ruzin A, et al. Molecular genetics of SaPI1 – a mobile pathogenicity island in Staphylococcus aureus. Mol Microbiol. 2001;41:365–377. doi: 10.1046/j.1365-2958.2001.02488.x. [DOI] [PubMed] [Google Scholar]
- Sun F, et al. Aureusimines in Staphylococcus aureus are not involved in virulence. PLoS ONE. 2010;5:e15703. doi: 10.1371/journal.pone.0015703. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ubeda C, et al. Specificity of staphylococcal phage and SaPI DNA packaging as revealed by integrase and terminase mutations. Mol Microbiol. 2009;72:98–108. doi: 10.1111/j.1365-2958.2009.06634.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- van Wamel WJ, et al. The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on beta-hemolysin-converting bacteriophages. J Bacteriol. 2006;188:1310–1315. doi: 10.1128/JB.188.4.1310-1315.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Villaruz AE, et al. A point mutation in the agr locus rather than expression of the Panton-Valentine leukocidin caused previously reported phenotypes in Staphylococcus aureus pneumonia and gene regulation. J Infect Dis. 2009;200:724–734. doi: 10.1086/604728. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wyatt MA, et al. Staphylococcus aureus nonribosomal peptide secondary metabolites regulate virulence. Science. 2010;329:294–296. doi: 10.1126/science.1188888. [DOI] [PubMed] [Google Scholar]
- Yoong P, Pier GB. Immune-activating properties of panton-valentine leukocidin improve the outcome in a model of methicillin-resistant Staphylococcus aureus pneumonia. Infect Immun. 2012;80:2894–2904. doi: 10.1128/IAI.06360-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
